Publications Available on this website

• New York City Department of Buildings Updates its Guidance on Essential Construction Activities, Client Advisories, April 16, 2020
• Empire State Development Modifies Guidance on In-Person Real Estate Activities, Client Advisory, April 10, 2020
• Empire State Development Updates Guidance on Essential Construction Projects During COVID-19, Client Advisory, April 10, 2020
• New York’s Department of Environmental Conservation Provides Guidance on “Essential” Environmental Cleanup and Brownfield Activities, Client Advisory, April 3, 2020
• Empire State Development Provides Guidance on Essential Real Estate Activities, Client Advisory, April 2, 2020
• New York City Department of Buildings Provides Guidance on Essential v. Non-Essential Construction Projects, Including Permissible Affordable Housing Projects, Client Advisory, March 31, 2020
• New York Governor Expands Closure of Many (But Not All) Construction Projects Due to COVID-19, Client Advisory, March 27, 2020
• Guidance on Cybersecurity: The HIPAA Breach Notification Rule, Client Advisory, July 14, 2017
• Guidance on Cybersecurity: The HIPAA Security Rule, Client Advisory, February 14, 2017
• Police Departments Should Review Their Policies and Procedures to Protect Prisoners, Client Advisory, June 30, 2016
• Off-Label Use and the False Claims Act: Has the Second Circuit Signaled A Change in the Winds After U.S. v. Pfizer?, Client Advisory, June 30, 2016
• Key Compliance Issues to Keep an Eye On in 2015: Off-Label Marketing and Sunshine Act Reporting, Pharmaceutical Compliance Monitor, June 15, 2015
• Drug Manufacturer Challenges the Constitutionality of FDA Regulations Related to Off-Label Marketing of Drugs and Medical Devices, Client Advisory, May 18, 2015
• New York’s Highest Court Rules on Restraining a Debtor’s Assets in Foreign Bank Branches, Client Advisory, November 13, 2014
• The Physician Payment Sunshine Act: A Dawning of New Reporting Requirements for Drug and Medical Device Manufacturers, Client Advisory, April 18, 2013
• Promoting Off-Label Uses of Drugs and Medical Devices: Manufacturers Should Exercise Caution Despite Reversal of Conspiracy Conviction in U.S. v. Caronia, Client Advisory, December 14, 2012